PSJ Web Site
J-STAGE
  Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended.


J.Health Sci., 57(2), 192-196, 2011

-Research Letter-

Effects of Lead Nitrate on Liver Weight and Serum Total Cholesterol Amounts in Stroke-Prone Spontaneously Hypertensive and Wistar-Kyoto Rats

Kiyomitsu Nemoto,*, a Takahiro Yasuda,a Tokihiro Hikida,a Sei Ito,a Misaki Kojima,b and Masakuni Degawaa

aDepartment of Molecular Toxicology and Global COE Program, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422-8526, Japan and bAnimal Genome Research Unit, Division of Animal Sciences, National Institute of Agrobiological Sciences, 2-1-2, Kannondai, Tsukuba 305-8602, Japan

The administration of inorganic lead (Pb) ion to rats is well known to induce liver hyperplasia with liver enlargement and hypercholesterolemia. In the present study, the sensitivities of stroke-prone sponta-neously hypertensive rat (SHRSP) and its normoten-sive control strain, Wistar-Kyoto rat (WKY), to these effects of Pb ion were estimated. Lead nitrate (LN) dissolved in a distillated water for injection was administered to male SHRSP and WKY by a single intravenous injection at a dose of 100 μmol/kg body weight. In WKY, significant increases in the liver weight were observed at 24 and 48 hr after LN-administration, while in SHRSP, no such significant increases were observed up to 48 hr later. On the other hand, increased levels of serum total cholesterol after LN-administration were significantly higher in SHRSP than in WKY at each time, although the constitutive (control) level was the opposite. The present findings suggest that there is different susceptibility between SHRSP and WKY to LN-induced liver hyperplasia and hypercholesterolemia and further indicate that development of hypercholesterolemia is not necessarily correlated with that of liver hyperplasia.